FSG-18322-69137
5 vaccinations
3 coded responses
63 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 050 / VT
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Moderna
-
2021-03-27
Registered in v-safe
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-10
- 2021-04-15
-
2021-04-22
Dose 2 — Moderna
- 2021-04-23
- 2021-04-24
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, DiarrheaAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-04-28
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-28
- 2021-06-03
- 2021-07-22
-
2021-08-23
Dose 3 — Moderna
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-08-26
- 2021-08-28
- 2021-08-29
- 2021-08-30
- 2021-09-06
- 2021-09-13
-
2021-09-20
Survey response — day 28, dose 3MedDRA: Pre-existing disease, Rheumatoid arthritis — Feeling: GoodFree text: Rheumatoid Arthritis FlareMedDRA releases: 2024-11 · check-in free text available
-
2021-09-27
Survey response — day 35, dose 3MedDRA: Rheumatoid arthritis — Feeling: GoodFree text: Rheumatoid ArthritisMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — day 42, dose 3MedDRA: Pre-existing disease, Rheumatoid arthritis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Rheumatoid Arthritis flareMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-12
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-22
- 2022-02-22
-
2022-02-24
Dose 4 — Moderna
- 2022-02-24
- 2022-02-25
- 2022-02-26
- 2022-02-27
- 2022-02-28
- 2022-03-01
- 2022-03-02
- 2022-03-03
- 2022-03-10
- 2022-03-17
- 2022-03-24
- 2022-03-31
- 2022-04-07
- 2022-05-27
- 2022-08-25
-
2022-09-30
Dose 5 — Moderna
- 2022-09-30
- 2022-10-02
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-06
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-12-30
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Moderna | |
| 2 | 2021-04-22 | Moderna | |
| 3 | 2021-08-23 | Moderna | No |
| 4 | 2022-02-24 | Moderna | No |
| 5 | 2022-09-30 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 9 — day 28, dose 3
Symptoms: Rheumatoid Arthritis Flare
Release 9 — day 35, dose 3
Symptoms: Rheumatoid Arthritis
Release 10 — day 42, dose 3
Symptoms: Rheumatoid Arthritis flare
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rheumatoid arthritis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release